Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders' Equity (unaudited)

v3.20.1
Condensed Consolidated Statements of Changes in Shareholders' Equity (unaudited) - USD ($)
$ in Thousands
Common Stock
Additional paid-in capital
Accumulated deficit
Total
Balance at beginning at Dec. 31, 2018 $ 2 $ 79,893 $ (61,378) $ 18,517
Balance at beginning (in shares) at Dec. 31, 2018 21,440,148      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common shares upon exercise of options 2 2
Issuance of common shares upon exercise of options (in shares) 416      
Issuance of common shares upon vesting of restricted stock units
Issuance of common shares upon vesting of restricted stock units (in shares) 10,313      
Share based compensation 837 837
Share based compensation (in shares)      
Net loss     (6,273) (6,273)
Balance at end at Mar. 31, 2019 $ 2 80,732 (67,651) 13,083
Balance at end (in shares) at Mar. 31, 2019 21,450,877      
Balance at beginning at Dec. 31, 2019 $ 3 102,789 (84,464) 18,328
Balance at beginning (in shares) at Dec. 31, 2019 28,811,087      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common shares upon vesting of restricted stock units
Issuance of common shares upon vesting of restricted stock units (in shares) 15,070      
Issuance of common shares upon cashless exercise of options (in shares)      
Share based compensation 804 $ 804
Share based compensation (in shares)      
Net loss (6,511) (6,511)
Balance at end at Mar. 31, 2020 $ 3 $ 103,593 $ (90,975) $ 12,621
Balance at end (in shares) at Mar. 31, 2020 28,826,157